The director of Russia’s Direct Investment Fund (RDIF), Kirill Dmitriev, announced that Brazil has been chosen to produce the Sputnik V Covid-19 vaccine, while the medicine will be distributed to several other countries in Latin America as early as December, according to local media.
“We believe that we can supply Latin America in December, we will produce dozens of millions of doses in December […] and actively supply them in January,” Mr. Dmitriev was quoted as saying.
Sputnik V was the first Covid-19 vaccine to be produced and is currently in phase-three trials with patients in Russia, Venezuela, the United Arab Emirates, and Belarus. The vaccine will also be produced in India, China, and South Korea, according to Mr. Dmitriev.
He added that they aim to obtain fast-tracked regulatory approval in all countries. Besides the current deals with Brazil and Mexico, the RDIF hopes to sign agreements with Argentina and Peru. Currently, Russia has agreed on deals with local governments in the Brazilian states of Bahia and Paraná, but health regulator Anvisa is still evaluating whether national tests will be possible.
Support this coverage →
Search
